A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.
Germline BRCA1 mutations predispose to breast cancer. To identify genetic modifiers of this risk, we performed a genome-wide association study in 1,193 individuals with BRCA1 mutations who were diagnosed with invasive breast cancer under age 40 and 1,190 BRCA1 carriers without breast cancer diagnosis over age 35. We took forward 96 SNPs for replication in another 5,986 BRCA1 carriers (2,974 individuals with breast cancer and 3,012 unaffected individuals). Five SNPs on 19p13 were associated with breast cancer risk (P(trend) = 2.3 × 10⁻⁹ to P(trend) = 3.9 × 10⁻⁷), two of which showed independent associations (rs8170, hazard ratio (HR) = 1.26, 95% CI 1.17-1.35; rs2363956 HR = 0.84, 95% CI 0.80-0.89). Genotyping these SNPs in 6,800 population-based breast cancer cases and 6,613 controls identified a similar association with estrogen receptor-negative breast cancer (rs2363956 per-allele odds ratio (OR) = 0.83, 95% CI 0.75-0.92, P(trend) = 0.0003) and an association with estrogen receptor-positive disease in the opposite direction (OR = 1.07, 95% CI 1.01-1.14, P(trend) = 0.016). The five SNPs were also associated with triple-negative breast cancer in a separate study of 2,301 triple-negative cases and 3,949 controls (P(trend) = 1 × 10⁻⁷) to P(trend) = 8 × 10⁻⁵; rs2363956 per-allele OR = 0.80, 95% CI 0.74-0.87, P(trend) = 1.1 × 10⁻⁷
23 references, click to expand
-
A BRCA1 nonsense mutation causes exon skipping.Am J Hum Genet. 1998 Mar;62(3):713-5 PMID: 9497265
-
MERIT40 facilitates BRCA1 localization and DNA damage repair.Genes Dev. 2009 Mar 15;23(6):719-28 PMID: 19261748
-
Variation of breast cancer risk among BRCA1/2 carriers.JAMA. 2008 Jan 9;299(2):194-201 PMID: 18182601
-
Genome-wide association study identifies novel breast cancer susceptibility loci.Nature. 2007 Jun 28;447(7148):1087-93 PMID: 17529967
-
NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control.Genes Dev. 2009 Mar 15;23(6):729-39 PMID: 19261749
-
Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population.Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3770-4 PMID: 16537453
-
A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes.Nat Genet. 2001 Jan;27(1):55-8 PMID: 11137998
-
The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.J Clin Oncol. 2002 May 1;20(9):2310-8 PMID: 11981002
-
Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.Nat Genet. 2007 Jul;39(7):865-9 PMID: 17529974
-
MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks.Genes Dev. 2009 Mar 15;23(6):740-54 PMID: 19261746
-
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.Am J Hum Genet. 2008 Apr;82(4):937-48 PMID: 18355772
-
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.Am J Hum Genet. 2003 May;72(5):1117-30 PMID: 12677558
-
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.Clin Cancer Res. 2008 May 1;14(9):2861-9 PMID: 18451254
-
The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons.Hum Mol Genet. 2002 Nov 1;11(23):2805-14 PMID: 12393792
-
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype.Clin Cancer Res. 2005 Jul 15;11(14):5175-80 PMID: 16033833
-
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.Hum Mol Genet. 2009 Nov 15;18(22):4442-56 PMID: 19656774
-
Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer.Nat Genet. 2008 Jun;40(6):703-6 PMID: 18438407
-
The 185delAG mutation (c.68_69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon.Hum Mutat. 2006 Oct;27(10):1024-9 PMID: 16941470
-
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.Nat Genet. 2007 Jul;39(7):870-4 PMID: 17529973
-
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.Nature. 2007 Jun 7;447(7145):661-78 PMID: 17554300
-
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.Am J Hum Genet. 2007 Dec;81(6):1186-200 PMID: 17999359
-
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.Br J Cancer. 2008 Apr 22;98(8):1457-66 PMID: 18349832
-
Overcoming the winner's curse: estimating penetrance parameters from case-control data.Am J Hum Genet. 2007 Apr;80(4):605-15 PMID: 17357068
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: [email protected]
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
